510(k) · Cleared
ClearedPC Ecg 1200W System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Norav Medical, Ltd. · MWI Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)
Cleared on Apr 25, 2008 as substantially equivalent to K000404 (Norav Medical, Ltd., 2000) after a 94-day review. Its family tree reaches back 1 generation to 2000. 3 later devices descend from it.
- Decided
- Apr 25, 2008
- Review
- 94 days
- Class
- Class II
- Product code
- MWI
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K000404 (2000). 3 later devices descend from it, 2 citing it directly.
- Root · 1 generation backK000404 PC ECG 1200Norav Medical, Ltd. · 2000
- This deviceK080141 PC Ecg 1200W SystemNorav Medical, Ltd. · 2008
- Descendant · cites it directly · 1 of its ownK100813 QRS Card S-T Segment Analysis Patient Monitoring System Model: QRS…Pulse Biomedical, Inc. · 2010
- Descendant · 2 generations on · 0 of its ownK142352 CardiacLinxRoss Medical Technology, Inc. · 2015
- Descendant · cites it directly · 0 of its ownK110463 Pcecg-1200 System with Modular Ecg Analysis System (Means)Norav Medical, Ltd. · 2011
Most influential descendants
Showing 3 of 3 · See all- K100813QRS Card S-T Segment Analysis Patient Monitoring System Model: QRS Card UsbPulse Biomedical, Inc. · 2010 · cites it directly1descendant
- K142352CardiacLinxRoss Medical Technology, Inc. · 2015 · 2 generations on0descendants
- K110463Pcecg-1200 System with Modular Ecg Analysis System (Means)Norav Medical, Ltd. · 2011 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K000404 | PC ECG 1200 | Norav Medical, Ltd. | 2000 | — |
| 0 (this device) | K080141 | PC Ecg 1200W System | Norav Medical, Ltd. | 2008 | — |
| +1 | K100813 | QRS Card S-T Segment Analysis Patient Monitoring System Model: QRS Card Usb | Pulse Biomedical, Inc. | 2010 | — |
| +2 | K142352 | CardiacLinx | Ross Medical Technology, Inc. | 2015 | — |
| +1 | K110463 | Pcecg-1200 System with Modular Ecg Analysis System (Means) | Norav Medical, Ltd. | 2011 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2015 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MWI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MWI device
- #1 K230457 Empatica Health Monitoring Platform…score 28.0 · 39 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K000404 | PC ECG 1200Summary page 1…ial Equivalence 21 CFR 807.92(a)(3) The clearance for the PC ECG 1200W System is sought on the grounds of its claimed substantial equivalence (SE) to Norav's PC ECG 1200 k000404 for complete physical and functional identity except the capability of wireless data communication. Device Definition 21 CFR 807.… | 2000 |
What descends from it? (3)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All MWI devicesMWI Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms): FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.
FDA decisions per year · MWI
4in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MWI
247in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MWI
9so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MWI
182in 2025
MAUDE reports naming product code MWI, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 9 | 42 | 1 | 3 |
| 2008 | 9 | 49 | 1 | 3 |
| 2009 | 6 | 112 | 2 | 20 |
| 2010 | 17 | 58 | 2 | 17 |
| 2011 | 11 | 78 | 3 | 16 |
| 2012 | 13 | 104 | 5 | 31 |
| 2013 | 20 | 85 | 3 | 42 |
| 2014 | 16 | 148 | 6 | 30 |
| 2015 | 19 | 127 | 1 | 31 |
| 2016 | 12 | 165 | 0 | 51 |
| 2017 | 13 | 205 | 2 | 85 |
| 2018 | 11 | 217 | 0 | 158 |
| 2019 | 14 | 255 | 4 | 169 |
| 2020 | 8 | 138 | 0 | 110 |
| 2021 | 9 | 161 | 0 | 188 |
| 2022 | 5 | 231 | 2 | 168 |
| 2023 | 8 | 250 | 0 | 179 |
| 2024 | 10 | 202 | 5 | 120 |
| 2025 | 4 | 247 | 0 | 182 |
| 2026 | 6 | 239 | 9 | — |
What is it indicated for?
ECG intended use: ECG is intended to disclose either normal condition or patterns of arrhythmia, myocardial ischeria, rate abnormalities, or features of prognostic value in patients: 1)suspected of cardiac abnormalities, or 2) in populations of patients at an age or period in which a routine baseline evaluation of ECG characteristics are desired. 3) QT Analysis is useful in the assessment of long QT syndrome (LQTS). In some instances, LQTS can be…
Read the full statement (393 words)
ECG intended use:
ECG is intended to disclose either normal condition or patterns of arrhythmia, myocardial ischeria, rate abnormalities, or features of prognostic value in patients:
1)suspected of cardiac abnormalities, or
2) in populations of patients at an age or period in which a routine baseline evaluation of ECG characteristics are desired.
3) QT Analysis is useful in the assessment of long QT syndrome (LQTS). In some instances, LQTS can be corrected by phanrmacologic therapy. QT analysis is also used to measure QT dispersion, the difference between maximal and minimal QT values. QT dispersion is a measure of the inhomogeneity of ventricular repolarization.
4) The PC ECG 1200W System has been tested to measure Heart Rate Variability within 1 millisecond tolerance. The clinical significance of Heart Rate Variability measures should be determined by a physician.
5) The PC ECG 1200W System has been tested to measure Late Potential within 1 millisecond tolerance in the time domain, and 1 microvolt tolerance in voltage. The clinical significance of Heart Rate Variability measures should be determined by a physician.
Stress testing intended use:
Angina pectoris (chest pain) is a clinical syndrome resulting from myocardial ischemia, indicative of a reduced blood supply to the cardiac muscle. The electrocardiogram may establish the diagnosis of ischemic heart disease if characteristic changes are present. Stress testing is the most widely used method to decide whether this chest pain is related to myocardial ischemia, and thereby coronary artery disease. In stress testing, the contractile capability of the heart muscle is monitored via ECG during patient exercise. Patients are exercised by bicycle, treadmill, or other means while continuously monitoring the ECG. Exercise loads are determined by predefined protocols. The ECG signals are recorded for the resting, exercise and recovery portions of the exercise protocol. The changes in ECG waveforms are compared to the resting ECG records. Although not necessary, most of the commercial stress test systems control the bicycle or treadmill automatically according to the requirements of the chosen protocol.
ST segment monitoring is intended as an aid in the evaluation of myocardial ischemia in patients with known or suspected coronary artery disease. The ST segment algorithm has been tested for accuracy of the ST segment data, and a database has been used as a tool for performance testing. The significance of the ST segment changes must be determined by a physician.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K080141 · printed Nov 6, 2026
Cite this page
510(k) Report. “K080141: PC Ecg 1200W System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080141
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026